ArticleJournal of enzyme inhibition and medicinal chemistry2023

Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity.

Ashraf K El-Damasy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.